Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDInfinity Pharmaceuticals, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/10/2023 | Q2 2023 | N/A | -$0.11 | N/A | N/A | $583,000 |
| 05/09/2023 | Q1 2023 | -$0.11 | -$0.12 | -0.01 | N/A | $731,000 |
| 03/28/2023 | Q4 2022 | N/A | -$0.10 | N/A | N/A | $543,000 |
| 11/14/2022 | Q3 2022 | -$0.05 | -$0.12 | -0.07 | N/A | $712,000 |
| 08/09/2022 | Q2 2022 | -$0.14 | -$0.13 | 0.01 | N/A | $686,000 |
| 05/03/2022 | Q1 2022 | -$0.14 | -$0.14 | 0 | N/A | $652,000 |
| 03/29/2022 | Q4 2021 | N/A | -$0.13 | N/A | N/A | $451,000 |
| 11/02/2021 | Q3 2021 | -$0.14 | -$0.12 | 0.02 | N/A | $428,000 |
| 07/27/2021 | Q2 2021 | -$0.13 | -$0.13 | 0 | N/A | $512,000 |
| 05/13/2021 | Q1 2021 | -$0.14 | -$0.15 | -0.01 | N/A | $467,000 |
| 03/16/2021 | Q4 2020 | -$0.16 | -$0.17 | -0.01 | N/A | $436,000 |
| 11/09/2020 | Q3 2020 | -$0.15 | -$0.16 | -0.01 | N/A | $496,000 |
| 07/30/2020 | Q2 2020 | -$0.20 | -$0.16 | 0.04 | N/A | $360,000 |
| 05/11/2020 | Q1 2020 | -$0.09 | -$0.19 | -0.1 | N/A | $428,000 |
| 03/03/2020 | Q4 2019 | -$0.19 | -$0.20 | -0.01 | N/A | $308,000 |
| 10/30/2019 | Q3 2019 | -$0.18 | -$0.20 | -0.02 | N/A | $343,000 |
| 07/30/2019 | Q2 2019 | -$0.15 | -$0.18 | -0.03 | N/A | $257,000 |
| 05/07/2019 | Q1 2019 | -$0.05 | -$0.24 | -0.19 | N/A | $2.14 M |
| 03/14/2019 | Q4 2018 | -$0.17 | -$0.14 | 0.03 | N/A | $146,000 |
| 11/05/2018 | Q3 2018 | -$0.15 | $0.23 | 0.38 | N/A | $22.00 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Infinity Pharmaceuticals, Inc. Earnings: FAQ's
Infinity Pharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 13th, 2023 based offlast year's report dates.
In the previous quarter, Infinity Pharmaceuticals, Inc. (:INFI) reported $-0.11 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.12 by $0.01.
The conference call for Infinity Pharmaceuticals, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Infinity Pharmaceuticals, Inc.'s latest earnings report can be read online.
Infinity Pharmaceuticals, Inc. (:INFI) has a recorded annual revenue of $2.59 M.
Infinity Pharmaceuticals, Inc. (:INFI) has a recorded net income of $-43,256,000.Infinity Pharmaceuticals, Inc. has generated $-0.48 earnings per share over the last four quarters.
Infinity Pharmaceuticals, Inc. (:INFI) has a price-to-earnings ratio of -0.02 and price/earnings-to-growth ratio is -0.